Detection of Human Cytomegalovirus DNA in Plasma from Patients with Brain Tumors Using a Sensitive qPCR Assay

Inti Peredo H; Yaiw KC; Bartek J; Rahbar A; Su00f6derberg-Naucler C

Inti Peredo H, Yaiw KC, Bartek J, Rahbar A and Su00f6derberg-Naucler C

Volume6-Issue9
Dates: Received: 2025-09-06 | Accepted: 2025-09-20 | Published: 2025-09-23
Pages: 1353-1362

Abstract

Background: Human Cytomegalovirus (HCMV) has been detected in tissue samples from patients with glioblastoma, but its presence in blood has been less studied.
Methods: In this prospective study, we analyzed the levels of HCMV-DNA in 59 plasma samples obtained from patients with brain tumors and from 114 healthy blood donors as controls. Detection was performed using a sensitive qPCR assay.
Results: HCMV-IE DNA was detected in plasma samples from patients with glioblastoma (n = 18), astrocytoma grades II-III (n = 11), and brain metastasis (n = 8). These groups showed significantly lower ΔCT values than healthy donors (p < 0.0001 for glioblastoma and astrocytoma; p = 0.0007 for brain metastases), consistent with higher circulating viral DNA levels than in controls. No significant difference was observed between patients with secondary glioblastoma and healthy donors.
Conclusions: HCMV-DNA is present at higher levels in plasma from patients with glioblastoma, astrocytoma grades II–III, and brain metastases compared with healthy individuals. Quantification of HCMV DNA in plasma by qPCR is a reliable approach for detecting HCMV in brain tumour patients.

FullText HTML FullText PDF DOI: 10.37871/jbres2190

Certificate of Publication

Copyright

How to cite this article

Inti Peredo H, Yaiw KC, Bartek J, Rahbar A and Söderberg-Naucler C. Detection of Human Cytomegalovirus DNA in Plasma from Patients with Brain Tumors Using a Sensitive qPCR Assay. J Biomed Res Environ Sci. 2025 Sept 23; 6(9): 1353- 1362. doi: 10.37871/jbres2190, Article ID: JBRES2190, Available at: https://www.jelsciences.com/articles/jbres2190.pdf

Subject area(s)

Brain Disorders

Brain Tumors

References

Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002 Jun 15;62(12):3347-50. PMID: 12067971.
Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L, Cobbs CS; HCMV and Gliomas Symposium. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012 Mar;14(3):246-55. doi: 10.1093/neuonc/nor227. Epub 2012 Feb 8. PMID: 22319219; PMCID: PMC3280809.
Söderberg-Nauclér C, Johnsen JI. Cytomegalovirus infection in brain tumors: A potential new target for therapy? Oncoimmunology. 2012 Aug 1;1(5):739-740. doi: 10.4161/onci.19441. PMID: 22934266; PMCID: PMC3429578.
Baryawno N, Rahbar A, Wolmer-Solberg N, Taher C, Odeberg J, Darabi A, Khan Z, Sveinbjörnsson B, FuskevÅg OM, Segerström L, Nordenskjöld M, Siesjö P, Kogner P, Johnsen JI, Söderberg-Nauclér C. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest. 2011 Oct;121(10):4043-55. doi: 10.1172/JCI57147. Epub 2011 Sep 26. PMID: 21946257; PMCID: PMC3195466.
Taher C, Frisk G, Fuentes S, Religa P, Costa H, Assinger A, Vetvik KK, Bukholm IR, Yaiw KC, Smedby KE, Bäcklund M, Söderberg-Naucler C, Rahbar A. High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers. Transl Oncol. 2014 Dec;7(6):732-40. doi: 10.1016/j.tranon.2014.09.008. PMID: 25500083; PMCID: PMC4311044.
Goerig NL, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt MA, Dörfler A, Engelhorn T, Eyüpoglu I, Rühle PF, Putz F, Semrau S, Gaipl US, Fietkau R. Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy. Clin Cancer Res. 2020 Jul 1;26(13):3259-3270. doi: 10.1158/1078-0432.CCR-19-3195. Epub 2020 Feb 14. PMID: 32060103.
Bhattacharjee B, Renzette N, Kowalik TF. Genetic analysis of cytomegalovirus in malignant gliomas. J Virol. 2012 Jun;86(12):6815-24. doi: 10.1128/JVI.00015-12. Epub 2012 Apr 11. PMID: 22496213; PMCID: PMC3393585.
Bianchi E, Roncarati P, Hougrand O, Guérin-El Khourouj V, Boreux R, Kroonen J, Martin D, Robe P, Rogister B, Delvenne P, Deprez M. Human cytomegalovirus and primary intracranial tumours: frequency of tumour infection and lack of correlation with systemic immune anti-viral responses. Neuropathol Appl Neurobiol. 2015 Feb;41(2):e29-40. doi: 10.1111/nan.12172. PMID: 25041908.
dos Santos CJ, Stangherlin LM, Figueiredo EG, Corrêa C, Teixeira MJ, da Silva MC. High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patients. J Med Virol. 2014 Nov;86(11):1953-61. doi: 10.1002/jmv.23820. Epub 2013 Oct 30. PMID: 24173908.
Libard S, Popova SN, Amini RM, Kärjä V, Pietiläinen T, Hämäläinen KM, Sundström C, Hesselager G, Bergqvist M, Ekman S, Zetterling M, Smits A, Nilsson P, Pfeifer S, de Ståhl TD, Enblad G, Ponten F, Alafuzoff I. Human cytomegalovirus tegument protein pp65 is detected in all intra- and extra-axial brain tumours independent of the tumour type or grade. PLoS One. 2014 Sep 30;9(9):e108861. doi: 10.1371/journal.pone.0108861. PMID: 25268364; PMCID: PMC4182568.
Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neurooncol. 2011 Jun;103(2):231-8. doi: 10.1007/s11060-010-0383-6. Epub 2010 Sep 5. PMID: 20820869.
Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol. 2008 Feb;10(1):10-8. doi: 10.1215/15228517-2007-035. Epub 2007 Oct 19. PMID: 17951512; PMCID: PMC2600830.
Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Strååt K, Stragliotto G, Söderberg-Nauclér C. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol. 2013 May;57(1):36-42. doi: 10.1016/j.jcv.2012.12.018. Epub 2013 Feb 4. PMID: 23391370.
Rahbar A, Peredo I, Solberg NW, Taher C, Dzabic M, Xu X, Skarman P, Fornara O, Tammik C, Yaiw K, Wilhelmi V, Assinger A, Stragliotto G, Söderberg-Naucler C. Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. Oncoimmunology. 2015 Feb 25;4(2):e982391. doi: 10.4161/2162402X.2014.982391. PMID: 25949880; PMCID: PMC4404865.
Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF. Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples. J Virol. 2012 Jan;86(2):854-64. doi: 10.1128/JVI.06097-11. Epub 2011 Nov 16. PMID: 22090104; PMCID: PMC3255835.
Sjöström S, Hjalmars U, Juto P, Wadell G, Hallmans G, Tjönneland A, Halkjaer J, Manjer J, Almquist M, Melin BS. Human immunoglobulin G levels of viruses and associated glioma risk. Cancer Causes Control. 2011 Sep;22(9):1259-66. doi: 10.1007/s10552-011-9799-3. Epub 2011 Jun 30. PMID: 21717196; PMCID: PMC3146711.
Stangherlin LM, Castro FL, Medeiros RS, Guerra JM, Kimura LM, Shirata NK, Nonogaki S, Dos Santos CJ, Carlan Silva MC. Human Cytomegalovirus DNA Quantification and Gene Expression in Gliomas of Different Grades. PLoS One. 2016 Jul 26;11(7):e0159604. doi: 10.1371/journal.pone.0159604. PMID: 27458810; PMCID: PMC4961403.
Baumgarten P, Michaelis M, Rothweiler F, Starzetz T, Rabenau HF, Berger A, Jennewein L, Braczynski AK, Franz K, Seifert V, Steinbach JP, Allwinn R, Mittelbronn M, Cinatl J Jr. Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics. Neuro Oncol. 2014 Nov;16(11):1469-77. doi: 10.1093/neuonc/nou167. Epub 2014 Aug 25. PMID: 25155358; PMCID: PMC4201076.
Cosset É, Petty TJ, Dutoit V, Cordey S, Padioleau I, Otten-Hernandez P, Farinelli L, Kaiser L, Bruyère-Cerdan P, Tirefort D, Amar El-Dusouqui S, Nayernia Z, Krause KH, Zdobnov EM, Dietrich PY, Rigal E, Preynat-Seauve O. Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response. Int J Cancer. 2014 Sep 15;135(6):1381-9. doi: 10.1002/ijc.28670. Epub 2014 May 8. PMID: 24347514; PMCID: PMC4235296.
Garcia-Martinez A, Alenda C, Irles E, Ochoa E, Quintanar T, Rodriguez-Lescure A, Soto JL, Barbera VM. Lack of cytomegalovirus detection in human glioma. Virol J. 2017 Nov 7;14(1):216. doi: 10.1186/s12985-017-0885-3. PMID: 29116009; PMCID: PMC5678593.
Holdhoff M, Guner G, Rodriguez FJ, Hicks JL, Zheng Q, Forman MS, Ye X, Grossman SA, Meeker AK, Heaphy CM, Eberhart CG, De Marzo AM, Arav-Boger R. Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization. Clin Cancer Res. 2017 Jun 15;23(12):3150-3157. doi: 10.1158/1078-0432.CCR-16-1490. Epub 2016 Dec 29. Erratum in: Clin Cancer Res. 2022 Apr 14;28(8):1737. doi: 10.1158/1078-0432.CCR-22-0565. PMID: 28034905; PMCID: PMC5474132.
Lehrer S, Green S, Rosenzweig KE, Rendo A. No circulating human cytomegalovirus in 14 cases of glioblastoma. Neuro Oncol. 2015 Feb;17(2):320. doi: 10.1093/neuonc/nou325. Epub 2014 Dec 1. PMID: 25452391; PMCID: PMC4288528.
Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR. Lack of association of herpesviruses with brain tumors. J Neurovirol. 2006 Apr;12(2):90-9. doi: 10.1080/13550280600654573. PMID: 16798670.
Priel E, Wohl A, Teperberg M, Nass D, Cohen ZR. Human cytomegalovirus viral load in tumor and peripheral blood samples of patients with malignant gliomas. J Clin Neurosci. 2015 Feb;22(2):326-30. doi: 10.1016/j.jocn.2014.06.099. Epub 2014 Oct 28. PMID: 25443081.
Yamashita Y, Ito Y, Isomura H, Takemura N, Okamoto A, Motomura K, Tsujiuchi T, Natsume A, Wakabayashi T, Toyokuni S, Tsurumi T. Lack of presence of the human cytomegalovirus in human glioblastoma. Mod Pathol. 2014 Jul;27(7):922-9. doi: 10.1038/modpathol.2013.219. Epub 2013 Dec 13. PMID: 24336154.
Peredo-Harvey I, Rahbar A, Söderberg-Nauclér C. Presence of the Human Cytomegalovirus in Glioblastomas-A Systematic Review. Cancers (Basel). 2021 Oct 9;13(20):5051. doi: 10.3390/cancers13205051. PMID: 34680198; PMCID: PMC8533734.
Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet. 2002 Nov 16;360(9345):1557-63. doi: 10.1016/S0140-6736(02)11524-8. PMID: 12443594.
Rådestad AF, Estekizadeh A, Cui HL, Kostopoulou ON, Davoudi B, Hirschberg AL, Carlson J, Rahbar A, Söderberg-Naucler C. Impact of Human Cytomegalovirus Infection and its Immune Response on Survival of Patients with Ovarian Cancer. Transl Oncol. 2018 Dec;11(6):1292-1300. doi: 10.1016/j.tranon.2018.08.003. Epub 2018 Aug 30. PMID: 30172882; PMCID: PMC6121833.
Samanta M, Harkins L, Klemm K, Britt WJ, Cobbs CS. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol. 2003 Sep;170(3):998-1002. doi: 10.1097/01.ju.0000080263.46164.97. PMID: 12913758.
Touma J, Liu Y, Rahbar A, Pantalone MR, Almazan NM, Vetvik K, Söderberg-Nauclér C, Geisler J, Sauer T. Detection of Human Cytomegalovirus Proteins in Paraffin-Embedded Breast Cancer Tissue Specimens-A Novel, Automated Immunohistochemical Staining Protocol. Microorganisms. 2021 May 13;9(5):1059. doi: 10.3390/microorganisms9051059. PMID: 34068349; PMCID: PMC8153275.
Wolmer-Solberg N, Baryawno N, Rahbar A, Fuchs D, Odeberg J, Taher C, Wilhelmi V, Milosevic J, Mohammad AA, Martinsson T, Sveinbjörnsson B, Johnsen JI, Kogner P, Söderberg-Nauclér C. Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target? Int J Cancer. 2013 Nov 15;133(10):2351-61. doi: 10.1002/ijc.28265. Epub 2013 Jul 13. PMID: 23661597.
Mitchell D, Archer G, Bigner D, Desjardins A, Friedman A, Friedman H, Lally-Goss D, Herndon J, Sharon McGehee S, McLendon R, Perry B, Reardon D, Rich J, Silverman S, Vrendenburgh J, Sampson J. Efficacy and immunologic effects of RNA-pulsed dendritic cell vaccines targeting human cytomegalovirus antigens in patients with glioblastoma. Cancer Research. 2008.
Stragliotto G, Pantalone MR, Rahbar A, Bartek J, Söderberg-Naucler C. Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients. Clin Cancer Res. 2020 Aug 1;26(15):4031-4039. doi: 10.1158/1078-0432.CCR-20-0369. Epub 2020 May 18. PMID: 32423968.
Batich KA, Reap EA, Archer GE, Sanchez-Perez L, Nair SK, Schmittling RJ, Norberg P, Xie W, Herndon JE 2nd, Healy P, McLendon RE, Friedman AH, Friedman HS, Bigner D, Vlahovic G, Mitchell DA, Sampson JH. Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination. Clin Cancer Res. 2017 Apr 15;23(8):1898-1909. doi: 10.1158/1078-0432.CCR-16-2057. PMID: 28411277; PMCID: PMC5559300.
Liau LM, Ashkan K, Brem S, Campian JL, Trusheim JE, Iwamoto FM, Tran DD, Ansstas G, Cobbs CS, Heth JA, Salacz ME, D'Andre S, Aiken RD, Moshel YA, Nam JY, Pillainayagam CP, Wagner SA, Walter KA, Chaudhary R, Goldlust SA, Lee IY, Bota DA, Elinzano H, Grewal J, Lillehei K, Mikkelsen T, Walbert T, Abram S, Brenner AJ, Ewend MG, Khagi S, Lovick DS, Portnow J, Kim L, Loudon WG, Martinez NL, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Giglio P, Gligich O, Krex D, Lindhorst SM, Lutzky J, Meisel HJ, Nadji-Ohl M, Sanchin L, Sloan A, Taylor LP, Wu JK, Dunbar EM, Etame AB, Kesari S, Mathieu D, Piccioni DE, Baskin DS, Lacroix M, May SA, New PZ, Pluard TJ, Toms SA, Tse V, Peak S, Villano JL, Battiste JD, Mulholland PJ, Pearlman ML, Petrecca K, Schulder M, Prins RM, Boynton AL, Bosch ML. Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. JAMA Oncol. 2023 Jan 1;9(1):112-121. doi: 10.1001/jamaoncol.2022.5370. PMID: 36394838; PMCID: PMC9673026.
Vanderbeek AM, Rahman R, Fell G, Ventz S, Chen T, Redd R, Parmigiani G, Cloughesy TF, Wen PY, Trippa L, Alexander BM. The clinical trials landscape for glioblastoma: is it adequate to develop new treatments? Neuro Oncol. 2018 Jul 5;20(8):1034-1043. doi: 10.1093/neuonc/noy027. PMID: 29518210; PMCID: PMC6280141.
Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4140-5. doi: 10.1073/pnas.0408994102. Epub 2005 Feb 28. PMID: 15738399; PMCID: PMC554799.
Söderberg-Nauclér C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 1997 Oct 3;91(1):119-26. doi: 10.1016/s0092-8674(01)80014-3. PMID: 9335340.
Matlaf LA, Harkins LE, Bezrookove V, Cobbs CS, Soroceanu L. Cytomegalovirus pp71 protein is expressed in human glioblastoma and promotes pro-angiogenic signaling by activation of stem cell factor. PLoS One. 2013 Jul 5;8(7):e68176. doi: 10.1371/journal.pone.0068176. PMID: 23861869; PMCID: PMC3702580.
Michaelis M, Doerr HW, Cinatl J Jr. Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol. 2009 May;198(2):79-81. doi: 10.1007/s00430-009-0107-8. Epub 2009 Feb 7. PMID: 19198878.
Söderberg-Nauclér C. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J Intern Med. 2006 Mar;259(3):219-46. doi: 10.1111/j.1365-2796.2006.01618.x. PMID: 16476101.
Dziurzynski K, Chang SM, Heimberger AB, Kalejta RF, McGregor Dallas SR, Smit M, Soroceanu L, Cobbs CS; HCMV and Gliomas Symposium. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro Oncol. 2012 Mar;14(3):246-55. doi: 10.1093/neuonc/nor227. Epub 2012 Feb 8. PMID: 22319219; PMCID: PMC3280809.
Farias KPRA, Moreli ML, Floriano VG, da Costa VG. Evidence based on a meta-analysis of human cytomegalovirus infection in glioma. Arch Virol. 2019 May;164(5):1249-1257. doi: 10.1007/s00705-019-04206-z. Epub 2019 Mar 19. PMID: 30888562.
Garcia-Martinez A. Lack of human cytomegalovirus in gliomas. A viral load analysis by quantitative real time-PCR. Laboratory Investigation. 2013.
Hashida Y, Taniguchi A, Yawata T, Hosokawa S, Murakami M, Hiroi M, Ueba T, Daibata M. Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects. Infect Agent Cancer. 2015 Jan 27;10:3. doi: 10.1186/1750-9378-10-3. PMID: 25685179; PMCID: PMC4328287.
Bahador M, Gras Navarro A, Rahman MA, Dominguez-Valentin M, Sarowar S, Ulvestad E, Njølstad G, Lie SA, Kristoffersen EK, Bratland E, Chekenya M. Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients. Oncoimmunology. 2017 Jun 5;6(8):e1336272. doi: 10.1080/2162402X.2017.1336272. PMID: 28919997; PMCID: PMC5593710.
Chen TQ, Li ZX, Jiang Y, Xu XD, Gan L, Wang BL. Detection of human cytomegalovirus in tumor tissue and peripheral blood samples of patients with gliomas. Int J Clin Exp Patho. 2017;10(2):1499-1508.
Dziurzynski K, Wei J, Qiao W, Hatiboglu MA, Kong LY, Wu A, Wang Y, Cahill D, Levine N, Prabhu S, Rao G, Sawaya R, Heimberger AB. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res. 2011 Jul 15;17(14):4642-9. doi: 10.1158/1078-0432.CCR-11-0414. Epub 2011 Apr 13. PMID: 21490182; PMCID: PMC3139801.
Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, Powell SZ, Grossman R, Grada Z, Scheurer ME, Hegde M, Leen AM, Bollard CM, Rooney CM, Heslop HE, Gottschalk S, Ahmed N. Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma. J Immunother. 2012 Feb-Mar;35(2):159-68. doi: 10.1097/CJI.0b013e318247642f. PMID: 22306904; PMCID: PMC3280423.
Ahlfors K, Forsgren M, Ivarsson SA, Harris S, Svanberg L. Congenital cytomegalovirus infection: on the relation between type and time of maternal infection and infant's symptoms. Scand J Infect Dis. 1983;15(2):129-38. doi: 10.3109/inf.1983.15.issue-2.01. PMID: 6308752.
Peredo-Harvey I, Bartek J Jr, Ericsson C, Yaiw KC, Nistér M, Rahbar A, Söderberg-Naucler C. Higher Human Cytomegalovirus (HCMV) Specific IgG Antibody Levels in Plasma Samples from Patients with Metastatic Brain Tumors Are Associated with Longer Survival. Medicina (Kaunas). 2023 Jul 5;59(7):1248. doi: 10.3390/medicina59071248. PMID: 37512060; PMCID: PMC10384986.
Lisboa LF, Asberg A, Kumar D, Pang X, Hartmann A, Preiksaitis JK, Pescovitz MD, Rollag H, Jardine AG, Humar A. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation. 2011 Jan 27;91(2):231-6. doi: 10.1097/TP.0b013e3181ff8719. PMID: 21048530.
Ksouri H, Eljed H, Greco A, Lakhal A, Torjman L, Abdelkefi A, Ben Othmen T, Ladeb S, Slim A, Zouari B, Abdeladhim A, Ben Hassen A. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation. Transpl Infect Dis. 2007 Mar;9(1):16-21. doi: 10.1111/j.1399-3062.2006.00171.x. PMID: 17313466.
Hebart H, Müller C, Löffler J, Jahn G, Einsele H. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Bone Marrow Transplant. 1996 May;17(5):861-8. PMID: 8733710.
Tang W, Elmore SH, Fan H, Thorne LB, Gulley ML. Cytomegalovirus DNA measurement in blood and plasma using Roche LightCycler CMV quantification reagents. Diagn Mol Pathol. 2008 Sep;17(3):166-73. doi: 10.1097/PDM.0b013e3181599242. PMID: 18382366.
Rzepka M, Depka D, Gospodarek-Komkowska E, Bogiel T. Whole Blood versus Plasma Samples-How Does the Type of Specimen Collected for Testing Affect the Monitoring of Cytomegalovirus Viremia? Pathogens. 2022 Nov 19;11(11):1384. doi: 10.3390/pathogens11111384. PMID: 36422636; PMCID: PMC9697577.
Kullberg-Lindh C, Olofsson S, Brune M, Lindh M. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA. Transpl Infect Dis. 2008 Oct;10(5):308-15. doi: 10.1111/j.1399-3062.2008.00313.x. Epub 2008 May 7. PMID: 18466193.
Dioverti MV, Lahr BD, Germer JJ, Yao JD, Gartner ML, Razonable RR. Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease. Open Forum Infect Dis. 2017 Jul 8;4(3):ofx143. doi: 10.1093/ofid/ofx143. PMID: 28852681; PMCID: PMC5570102.
Nitsche A, Steuer N, Schmidt CA, Landt O, Ellerbrok H, Pauli G, Siegert W. Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol. 2000 Jul;38(7):2734-7. doi: 10.1128/JCM.38.7.2734-2737.2000. PMID: 10878073; PMCID: PMC87012.
Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, Smith TF, Paya CV. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation. 2002 Mar 27;73(6):968-73. doi: 10.1097/00007890-200203270-00025. PMID: 11923702.
Torii Y, Morioka I, Kakei Y, Fujioka K, Kakimoto Y, Takahashi N, Yoshikawa T, Moriuchi H, Oka A, Ito Y. Correlation of cytomegalovirus viral load between whole blood and plasma of congenital cytomegalovirus infection under valganciclovir treatment. BMC Infect Dis. 2023 Jan 19;23(1):31. doi: 10.1186/s12879-023-07995-6. PMID: 36658533; PMCID: PMC9850601.
Schuessler A, Smith C, Beagley L, Boyle GM, Rehan S, Matthews K, Jones L, Crough T, Dasari V, Klein K, Smalley A, Alexander H, Walker DG, Khanna R. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. Cancer Res. 2014 Jul 1;74(13):3466-76. doi: 10.1158/0008-5472.CAN-14-0296. Epub 2014 May 4. PMID: 24795429.